CONTEXT & RELEVANCE
Why run this survey now
Most diabetes device teams don't lose adherent patients purely on clinical efficacy. They lose them due to device handling friction, confusing titration guidance, inadequate onboarding support, poor hypoglycemia confidence, and misaligned refill touchpoints, none of which fully show up in prescription data or post-market surveillance reports.
If you are...
You're likely facing...
This will help answer...
RESEARCH THEMES
What This Survey Investigates
Eight interconnected research themes that map the complete diabetic patient journey from diagnosis to sustained self-management.
SAMPLING STRATEGY
Tell us about your ideal sample
Help us understand your target respondent profile. Select what applies, we'll design the optimal sample plan based on your inputs.
METHODOLOGY
Survey approach
For the Diabetic Patient Unmet Device Usability and Treatment Adherence Support Survey, we recommend a quant-first design with flexible data-collection modes to balance reach, depth, and verification.
EXECUTION PROCESS
How we execute
A proven 9-step process from scoping to delivery, designed to ensure quality, speed, and actionable insights.
Define the decision frame
Confirm objectives, target cohorts, geographies, and reporting cuts
Define the decision frame
Design the instrument
Build workstream modules mapped to outputs (drivers, friction, pricing, retention, trust)
Design the instrument
Lock the questionnaire
Review wording, sequencing, LOI, and competitive context; approve final version
Lock the questionnaire
Pilot and calibrate
Test comprehension and ease quality; refine quotas and remove friction where needed
Pilot and calibrate
Run fieldwork
Execute collection with active quota management and feasibility controls
Run fieldwork
Assure quality
Dedupe, attention checks, speed/consistency rules, removals with audit trail
Assure quality
Prepare the dataset
Clean data and deliver codebook/variable definitions
Prepare the dataset
Analyse and synthesise
Driver ranking, leakage diagnostics, pricing bands, segment insights
Analyse and synthesise
Deliver and align
Executive deck (optional dashboard) and leadership readout with recommendations
Deliver and align
COMMERCIAL TERMS
Request a Commercial Proposal
Pricing depends on cohort, geography, sample size, approach, LOI, and deliverables. Configure below for an indicative estimate.
Select Sample Size
Geography
Select Mode of Survey
Length of the Interview
+ applicable taxes
Cost Breakdown
Note: Estimate is indicative only. Final pricing is subject to scope finalization after discovery call.
REFERENCE CASELETS
Reference
Real-world examples of survey work in the chronic disease device and adherence space.
OBJECTIVE
WHAT WE DID
DELIVERED
Insulin delivery device friction & segment preference map (India)
CGM adoption messaging & HCP channel levers (South Asia)
OBJECTIVE
A specialty pharma client needed to isolate why insulin-dependent Type 2 patients across metro, Tier 1, and Tier 2 geographies switched between pen devices and vials , and which usability barriers drove early discontinuation within the first 90 days of prescription.
WHAT WE DID
Ran a structured quant survey across 480 patients, capturing device handling confidence, injection site discomfort, dose-setting legibility, refill access friction, and HCP instruction adequacy at initiation, segmented by treatment duration and prescriber channel.
DELIVERED
A usability friction map by device type and patient segment, a ranked barrier list across the first 90-day window, and a segment preference framework separating self-managing patients from caregiver-dependent users by geography and literacy level.
FREQUENTLY ASKED QUESTIONS
Common Questions
Answers to frequently asked questions about this survey mandate.
What decisions will this survey enable?
Who is the buyer vs who are the respondents?
Can we see differences between insulin-dependent patients, non-insulin oral therapy patients and newly diagnosed patients?
How will you measure device usability preference beyond simple ratings?
Will the survey map the full diabetes device and therapy adherence journey and drop-offs?
Can this survey inform product and pricing strategy?
How will findings improve our patient retention and commercial launch strategy?
Still have questions?
Schedule a discovery call to discuss your specific needs and get a custom quote.